A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders
NCT04482049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2023-11-18
Summary
The purpose of the study is to collect information on disease characteristics from adult patients diagnosed with fatty acid oxidation disorders (FAOD).
Conditions
- Fatty Acid Oxidation Disorder
Sponsors & Collaborators
-
Reneo Pharma Ltd
lead INDUSTRY
Principal Investigators
-
Melanie Gillingham, PhD, RD, LD · Dept of Molecular and Medical Genetics, Oregon Health and Science University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-15
- Primary Completion
- 2022-05-04
- Completion
- 2022-05-04
Countries
- United States
- Austria
- Belgium
- Czechia
- Denmark
- France
- Hungary
- Italy
- Poland
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Obesity and Fatty Acid Flux Comparison Trials
NCT00074945 ·Status: COMPLETED
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Evaluation of Body Iron Stores in Overweight Healthy Volunteers
NCT02304874 ·Status: COMPLETED ·Phase: NA
-
Fat-Associated Cardiovascular Organ Dysfunction
NCT02805478 ·Status: COMPLETED
-
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02363309 ·Status: COMPLETED
-
Body Fat Distribution and Fat Metabolism
NCT00475774 ·Status: COMPLETED ·Phase: NA
-
Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort
NCT00997165 ·Status: UNKNOWN
-
A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center
NCT05081440 ·Status: UNKNOWN
-
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
NCT05106049 ·Status: UNKNOWN
-
The Liver Health Study for Patients with NAFLD
NCT03151798 ·Status: COMPLETED ·Phase: NA
-
Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
NCT00510588 ·Status: COMPLETED ·Phase: NA
-
Characterization of Bile Acid Pathway in Obesity
NCT03341052 ·Status: COMPLETED ·Phase: NA
-
Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)
NCT03183193 ·Status: UNKNOWN ·Phase: NA
-
Characterization of Serum Proteome in Young Obese Subjects (POSING)
NCT05761210 ·Status: COMPLETED
-
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
NCT04141592 ·Status: RECRUITING
-
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NCT06135584 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Familial Partial Lipodystrophy Study
NCT02858830 ·Status: COMPLETED ·Phase: NA
-
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
NCT03394469 ·Status: UNKNOWN ·Phase: NA
-
Characteristics of NAFLD Among Type 2 Diabetes Patients
NCT04999124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance
NCT00422006 ·Status: COMPLETED ·Phase: NA
-
Registry for Patients With Lipodystrophy
NCT03553420 ·Status: RECRUITING
-
Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity
NCT01784289 ·Status: COMPLETED
-
Dysfunctional Adiposity and Glucose Impairment
NCT03506581 ·Status: COMPLETED
-
Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)
NCT05358496 ·Status: UNKNOWN
-
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
NCT05697991 ·Status: RECRUITING